| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
3e-15 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-14 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
6e-14 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-13 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
5e-13 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-12 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
3e-12 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
2e-11 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-11 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-10 |